Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Your monthly program includes: Once-weekly subcutaneous self-injection Triple receptor agonist targeting GLP-1, GIP, and glucagon Strongest weight loss data of any GLP compound to date Research compound offered under physician supervision No lab draw required
These are incretin hormones that regulate glucose homeostasis and appetite
They use products from licensed pharmaceutical suppliers to guarantee safety and effectiveness
Post-injury treatment reduced hemorrhage, laceration, edema, and mortality
Gerstein HC, Mann JF, Hoogwerf B, Zinman B, Held C, Fisher M, Wolffenbuttel B, Bosch J, Richardson L, Pogue J, Heart Outcomes Prevention Evolution (HOPE) Study Investigators
Some participants lost more than 25 percent of their total body weight
US$ 22.67
US$ 23.89
US$ 24.05
US$ 23.68
